Marwan Sleiman, Phd Email & Phone Number

Paris, Fr

Boulogne Billancourt, Fr

(Including 8 months as ad-interim)Leading elafibranor (IQIRVO) launch in PBC globallyIndications:Rare liver disease- PBC (primary biliary cholangitis)- PSC (primary sclerosing cholangitis)

Boulogne Billancourt, Fr

- Lead the strategic direction and the development and implementation of both the Medical Education and External Engagement plans with key experts, centers and medical societies,- Lead the insight-generation strategy and implementation,- Lead and executed the company presence in congresses (symposia, medical booth, HCPs engagement, and cross-functional alignment)- Lead the co-development of care networks for an ultra-rare musculoskeletal disorder,- Approved and provided direction for the market research and external-facing-material developed by different departments (marketing, communication, market access…),- Participated in the design of the global integrated brand and medical plan for the 4 assets,

Basel, Ch

Part of Actelion pharmaceuticals Ltd. Global Research & Development department, my role focused on different aspects of "ponesimod" development plan and pre-launch in multiple sclerosis (MS):- Managed 4 clinical studies (Phase II and III) from the scientific and medical side, and acted as the first scientific and medical contact with the study sites’ teams (France & BeNeLux)- Proposed innovative ideas to optimise the studies’ conduct from both the medical viewpoint and the patient experience,- Identified, initiated and fostered a collaborative relationship with Key Opinion Leaders (KOL) and external stakeholders (patient advocacy groups, institutions…),- Developed and coordinated regional & international advisory boards (KOL, patient advocacy groups…) to better understand their needs and the future drug’s positioning,- Created Actelion and Janssen medical and R&D booth, and the relevant medical material, for regional and international meetings (ECTRIMS, EAN, JNLF…),- Created educational material and provided training for external and internal stakeholders,- Participated, with Global and EMEA, in the elaboration of the drug’s (ponesimod) future launch strategy.

Beerse, Be

Participated in the leading and coordination of a Medical Affairs Excellence and Transformational Change Management program aiming to optimize the role of (no less than 600) MSLs & MSL Managers and their engagement with external stakeholders in the EMEA region.

Beerse, Be

- Acted as the SME (subject matter expert) for ponesimpd in MS (multiple sclerosis)- Informed, reviewed & approved external-facing company material (drug & therapeutic area related) ensuring scientific accuracy & relevance, and compliance with EU & local healthcare compliance rules

Leverkusen, North Rhine-Westphalia, De

On behalf of Bayer Healthcare, and in contribution to Xarelto® (Rivaroxaban) success:- Presented medical and scientific information to various thought leaders, helping them better positioning Xarelto® in their therapeutic arsenal- Collaborated with sales representatives to optimise the medical communication impact

Bonn, De

On behalf of a pharmaceutical company, in preparation for the EU launch of an innovative product (a drug/device combination):- Identified current market and therapeutic area needs, and conducted extended research (including 30+ interviews with EU KOLs) to prepare the launch strategy- Built strategy recommendations for medical and medico-economic communication, and negotiated product’s country specific price models for EU5 countries

Luxembourg, Lu

Part of the immunology department:- Managed multiple research projects in immunology and oncology, from concept development to publication/presentation, within restraint budgets and timelines- Organised, with physicians and clinical investigators in EU and the Americas, patients’ identification and sample collection in accordance with ethical and legal frameworks- Presented scientific data in 10+ European and International scientific and medical congresses, and collected data, insuring competitive intelligence and scientific monitoring- Developed a broad network of contacts, and built collaboration projects with top research centres- Designed and developed a novel high throughput-analysis technique, and provided training for 35 EU platform managers

Master internship in Neuroscience : "Neuropeptide Y and its effect on 3 alpha,5 alpha-THP (tetrahydro progesterone) biogenesis in rat's Hippocampus and Amygdala"

Fr

Master internship in Molecular Biology and Virology: "Mechanistic study of HIV (Human Immunodeficiency Virus) RT (Reverse Transcriptase) inhibitors inducing DCT (Delayed Chain Termination)"

Summer internship in Microfluidics' applications in enzymes' function optimisation.

Specialised Masters, Biopharmaceutical Management

The Multi-Channel Patient Engagement Course

Doctor Of Philosophy (Ph.D.), Biology (Immunology)

Master'S Degree, Molecular And Cellular Pathophysiology

Master'S Degree, Molecular And Structural Biology

Master'S Degree, Biochemistry